Gielen, Evelien
Aldvén, Martina
Kanis, John A.
Borgström, Fredrik
Senior, Emmanuelle
Willems, Damon
Funding for this research was provided by:
UCB Pharma
Amgen Inc
Article History
Received: 12 September 2023
Accepted: 20 February 2024
First Online: 2 April 2024
Declarations
:
: EG is a board member of the Belgian Bone Club. EG has received consultancy fees and lecture fees from Danone, Amgen, Orifarm and UCB, unrelated to this work.MA is an employee of Quantify Research which was contracted and paid by UCB Pharma to conduct the study. FB owns stock in Quantify Research. The authors did not receive direct payment as a result of this work outside of their normal salary payments. DW and ES are employees and shareholders of UCB Pharma. JAK is a director of Osteoporosis Research Ltd that maintains FRAX®.